Now Animals can Also Spread Malaria, Researchers Confirm Zoonotic Transmission

IMT News Desk
IMT News Desk
· 5 min read

Zoonotic transmission of malaria confirmed in recent cases in the Atlantic Forest region of southern Brazil. Molecular analysis of 28 human cases of malaria confirms presence of Plasmodium simium, a parasite usually only found in monkeys, and not P vivax (a human parasite) as previously diagnosed.

Malaria was eliminated from southern and southeastern Brazil over 50 years ago, but a number of cases each year in areas of the Atlantic Forest prompted researchers to investigate the possibility of zoonotic transmission – where human beings become infected, via a mosquito bite, with a malaria parasite that usually infects monkeys.

Now, analysis of DNA samples has confirmed that 28 such cases of malaria were caused by zoonotic transmission of Plasmodium simium, a parasite usually only found in monkeys, and not the human parasite Plasmodium vivax, as previously thought.
The authors of the analysis say that screening of local monkeys and mosquitos will be required to evaluate the extent of the emerging zoonotic threat to public health, and to the potential of malaria elimination in Brazil. The study is published in The Lancet Global Health journal.
Once prevalent in the whole country, malaria transmission in Brazil now occurs almost entirely (over 99% of cases) in the northern Amazon region. However, between 2006 and 2014, 43 cases of malaria were reported in the Atlantic Forest area in southern Brazil, and an additional 49 occurred in 2015-16. Samples from 33 of these cases were included in this study. DNA from 28 cases was successfully sequenced and all were confirmed to be P simium, rather than P vivax. All patients had entered the forest or visited the surrounding area. Fever was the main symptom, no patient was admitted to hospital, and all made full recoveries following treatment.

“There is no evidence that zoonotic malaria can be transmitted from human to human via mosquitoes. In addition there is no current threat to people in the city of Rio de Janeiro, or in other non-forest areas of the Rio de Janeiro state, where transmission of the disease does not exist. However, its unique mode of transmission via monkeys and the fact that it occurs in areas of high forest coverage mean that zoonotic malaria poses a unique problem for malaria control efforts and may complicate the drive towards eventual elimination of the disease. Although benign and treatable, visitors should follow measures to avoid insect bites when going into the forest”, says author Dr Patrícia Brasil, Instituto Nacional de Infectologia Evandro Chagas, Rio de Janeiro, Brazil.

Zoonotic malaria occurs when human beings become infected with a mosquito-borne malaria parasite that usually infects non-human primates only. The zoonotic parasite Plasmodium knowlesi, transmitted from the macaque monkey, is responsible for a high proportion of human malaria cases in southeast Asia. P simium is transmitted via the Anopheles mosquito and is known to infect some species of howler and capuchin monkeys in the Atlantic Forest region of south and southeastern Brazil.

“In the 1960s, there was a probable case of zoonotic malaria described in a forest guard in the Atlantic Forest of São Paulo, but until now, there has been no molecular evidence of the parasite being present in humans. This is the first demonstration of P simium naturally infecting human beings in forest locations in a region considered to have eliminated transmission of malaria at least 50 years ago”, says author Dr Cláudio Tadeu Daniel-Ribeiro, Instituto Oswaldo Cruz, Rio de Janeiro, Brazil.

The authors note that since samples from previous years have not yet been tested, it is not possible to establish whether the parasite has only recently acquired the ability to frequently infect human beings, or if zoonotic malaria has previously infected human beings in this region, prior to the region eliminating the disease.

In a linked Comment, Matthew J Grigg, Menzies School of Health Research, Darwin, Australia and Georges Snounou, Sorbonne University, Paris, France, writes: “A large focus of zoonotic P knowlesi human infections (historically misdiagnosed as Plasmodium malariae by microscopy) was reported in Malaysia in 2004, where it is now the predominant cause of malaria (…).” They note that the findings make “this part of Brazil the site of a second global focus of zoonotic malaria.” They add: “This important study raises a number of remaining questions. Firstly, it becomes imperative to obtain the full genome of P simium to confirm or reject synonymy with P vivax. An anthropozoonotic P vivax reservoir in Brazilian monkeys would pose a substantial threat to malaria elimination throughout the continent and possibly beyond, including potential onwards transmission from hypnozoite relapses. One priority should be to investigate the natural history and biology of these two parasites in their non-human primate hosts. Evaluation of the geographical distribution and prevalence of P simium in both monkey hosts and mosquito vectors will also assist in accurately defining the population at risk. The clinical features and pathogenesis of P simium also remain poorly defined.”

 

 

Read Next

Alembic Pharmaceuticals Limited announces USFDA Tentative Approval for Larotrectinib Capsules
News
June 11, 2026

Alembic Pharmaceuticals Limited announces USFDA Tentative Approval for Larotrectinib Capsules

Alembic Pharmaceuticals Limited (Alembic) announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Larotrectinib Capsules, 25 mg and 100 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Vitrakvi Capsules, 25 mg and 100 mg, of […]
Article by: IMT News Desk
DFE Pharma earns third consecutive EcoVadis Gold Medal for sustainability performance 
News
June 11, 2026

DFE Pharma earns third consecutive EcoVadis Gold Medal for sustainability performance 

DFE Pharma has earned its third consecutive Gold Medal from EcoVadis, the world leader in corporate sustainability assessments, in recognition of its strong performance in the four themes rated: Environment, Labor & Human Rights, Ethics and Sustainable Procurement. This distinction places DFE Pharma in the top 5% of companies, reflecting the company’s focused efforts to […]
Article by: IMT News Desk
Oval Fertility Inks MoU with Merck to Advance Reproductive Care Standards in India
News
June 11, 2026

Oval Fertility Inks MoU with Merck to Advance Reproductive Care Standards in India

Oval Advanced Fertility Care and Merck Specialities Private Limited, the Indian healthcare arm of Merck KGaA, Darmstadt, Germany and a global leader in fertility sciences with decades of scientific leadership in reproductive medicine, have signed a strategic Memorandum of Understanding (MOU).   India’s IVF market, valued at approximately USD 2.35 billion in 2024, is projected […]
Article by: IMT News Desk
Infosys-backed 4baseCare raises ₹128 crore, plans to take its cancer testing platform global
News
June 11, 2026

Infosys-backed 4baseCare raises ₹128 crore, plans to take its cancer testing platform global

Bengaluru-based precision oncology startup 4baseCare has raised ₹128 crore in its ongoing Series B funding round to expand its hospital-linked genomics laboratory network globally and scale its AI-powered precision oncology platform, OncoTwin. The latest funding round, which follows a first close of ₹90 crore co-led by Ashish Kacholia and Lashit Sanghvi with participation from existing […]
Article by: IMT News Desk